NovioSense is a pioneering brand that aims to free diabetics from the inconvenience and pain of traditional finger pricks for glucose monitoring. With a vision for patient comfort and shareholder value, NovioSense set out in 2012 to reinvent glucose measurement. By reimagining finger strip technology, NovioSense has developed a non-invasive device that allows users to monitor glucose levels on demand, unobtrusively, and without the need for painful blood draws.

Utilizing tears as a unique source of biomarkers, NovioSense's non-invasive sensor accurately detects trace levels of glucose and extrapolates them to blood glucose measurements. The device, designed for ease of use, features a small form factor that can be placed and removed behind the lower eyelid without specialist training. Smart hydrogel coatings ensure extended wear times, and the device employs the same robust enzymatic detection found in current state-of-the-art glucose monitors.

With plans to enter the market in 2020, NovioSense is poised to revolutionize glucose monitoring and provide a user-friendly alternative to the painful finger prick